Abstract
Introduction
Impaired renal function is a well-known independent risk factor for mortality and morbidity in patients with myocardial infarction (MI) [1, 2] . Several studies reported that impaired renal function is more prevalent in women, while female MI patients are generally older and have more comorbidity than male patients [2, 3] . The impact of gender difference on prognosis after ST-segment elevated MI (STEMI) has been a popular and debated topic in clinical practice [4] [5] [6] [7] [8] [9] [10] . Although many studies on the issue have consistently showed higher mortality in women compared with men after STEMI [4] [5] [6] [7] [8] [9] [10] , a limited number of studies have investigated gender influence on the prognostic impact of impaired renal function in patients with STEMI. Moreover, published studies yielded discrepant results regarding the impact of gender on the relationship between renal function and clinical outcomes in STEMI patients [11, 12] . Therefore, we undertook the present study to investigate how gender influences the prognostic impact of impaired renal function in patients with STEMI, in a cohort registered in the Korea Acute Myocardial Infarction Registry (KAMIR).
Methods

Korea Acute Myocardial Infarction Registry
The study population was derived from the KAMIR. The KAMIR is a Korean prospective, open, observational, multi-center online registry investigating the risk factors of mortality in MI patients since November 2005. Details of the KAMIR have been published elsewhere [2, 13] . We assessed a cohort of 8,063 consecutive patients who were admitted to the hospital between November 1, 2005, and July 31, 2008, and had a discharge diagnosis of STEMI, confirmed by both cardiac enzyme and electrocardiographic analyses. The diagnosis of STEMI was based on a suggestive history, with ST elevation > 2 mm in ≥ 2 precordial leads, ST elevation > 1 mm in ≥ 2 limb leads, or new left branch bundle block on a 12-lead electrocardiogram with a concomitant increase of cardiac markers ≥ twice the normal upper limit. We excluded patients who were not available for estimation of glomerular filtration rate (GFR) or who did not complete at least 1 year of follow-up. A final population of 7,679 patients was analyzed in this study.
Assessment of renal function
Renal function was assessed based on estimated GFR (eGFR). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation was used to calculate eGFR in mL/min/1.73 m 2 [14] . The eGFR was categorized as ≥ 90, 60-89, 30-59, and < 30 mL/min/1.73 m 2 , based on National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (KDOQI) chronic kidney disease (CKD) stages, but patients with CKD stages 4 and 5 were combined because of relatively small numbers in this category.
Statistical analysis
Continuous variables with normal distributions are presented as mean ± standard deviation and compared using Student's t-test. 
Results
Patients' baseline characteristics are presented in Table 1 . A total of 7,679 patients took part in the study, including 5,652 men (age, 59.8 ± 12.8) and 2,027 women (age, 71.4 ± 10.0). Women were older and had a higher prevalence of impaired renal function (20.2% vs. 38.9%, p < 0.001, defined as eGFR < 60 mL/min/1.73 m 2 ), hypertension, and DM, but had a lower BMI, eGFR, and rate-of-smoking history than men. Serum glucose, total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol were higher, while cardiac biomarkers and triglycerides were lower in women. At the time of arrival, women had a lower blood pressure and higher Killip class. Left ventricular ejection fraction did not differ between genders.
With regard to initial treatment strategy, conservative treatment was more commonly performed ; BMI -body mass index; eGFR -estimate glomerular filtration rate; DM -diabetes mellitus; IHD -ischemic heart disease; CK-MB -creatine kinase-MB; LDL -low density lipoprotein; HDL -high density lipoprotein; SBP -systolic blood pressure;
DBP -diastolic blood pressure; HR -heart rate; LVEF -left ventricular ejection fraction
Joon Seok Choi et al., Impact of impaired renal function in both genders in women, while PCI was undertaken at similar rates in both genders. However, many patients who did not undergo primary PCI underwent PCI before discharge, and overall PCI was less frequently performed in women (Table 2) . Women exhibited more multivessel involvement and less optimal post-procedure thrombosis in MI (TIMI) flow on angiographic findings (Table 3) . During hospitalization, standard medications known to improve survival after MI, such as anti-platelet agents, beta-blockers, and angiotensin-converting-enzyme inhibitors or angiotensin-receptor-blockers were less frequently used in women, while the use of anti-coagulation drugs and statins did not differ between genders (Table 2) . Subsequently, we analyzed baseline characteristics, hospital treatments and angiographic findings in patients with eGFR < 60 mL/min/1.73 m
.
As showed in all patients, there were similar differences between both genders with regard to baseline characteristics (Table 1) , and hospital treatments and angiographic findings did not differ between genders (Tables 2 and 3) .
Clinical outcomes were assessed by analysis of 1-month and 1-year mortalities. Women showed significantly higher mortality than men after STEMI (1-month mortality, 5.6% in men vs. 12.6% in women, p < 0.001; 1-year mortality, 6.8% in men vs. 14.4% in women, p < 0.001). Kaplan-Meier survival curves with log-rank test showed proportionally increased mortality according to the eGFR category in both genders (Fig. 1) . To adjust for possible confounding factors, Cox proportional regression analysis was performed. Decreased renal function was proportionally associated with increased unadjusted 1-month and 1-year mortalities in both genders. After adjusting for potential confounders, eGFR level less than 60 mL/min/1.73 m 2 remained a strong independent predictor for 1-month and 1-year mortalities in both genders (Table 4) . At each eGFR level, hazard ratios for women did not differ significantly from those for men. We performed an interaction test to investigate whether gender influenced mortality at each eGFR level after STEMI. The interaction test showed no significant interaction between gender and eGFR in 1-month mortality and 1-year mortality (p = 0.928, p = 0.903, respectively).
Discussion
In the present study, female STEMI patients were older and had more comorbidity, including impaired renal function, than males, which is consistent with the results of previous studies [4] [5] [6] [7] [8] [9] [10] . With regard to hospital management of STEMI, a higher proportion of patients received conservative treatment as an initial treatment strategy, and PCI was less frequently performed during the in-hospital period in women. Indeed, standard medications known to improve survival after MI *compared between men and women; **compared between men with eGFR < 60 mL/min/1.73 m 2 and women with eGFR < 60 mL/min/1.73 m 2 ; eGFR -estimate glomerular filtration rate; TIMI -thrombosis in myocardial infarction were less frequently used in women. Although women showed higher mortality in the present study, this might be attributed to differences in baseline characteristics and hospital management intensity. Previous studies reported conflicting results about gender effects on mortality after adjusting Joon Seok Choi et al., Impact of impaired renal function in both genders for multiple confounding factors. Some showed no gender effect on mortality after adjustment [4, 5, 7, 9] , and others concluded that gender was an independent risk factor for mortality after STEMI [6, 8, 10] . Recently, Kang et al. [9] reported that the gender effect was accounted for mostly by older age in women, complex comorbidities, and severe hemodynamic conditions at presentation; their study analyzed merged data from the KAMIR and the Korean Myocardial Infarction (KorMI) registry.
Previous studies regarding gender effects on the impact of impaired renal function in prognosis after STEMI produced highly discrepant and inconclusive results [3, 11, 12] . In the present study we investigated whether gender influences the impact of impaired renal function in STEMI patients, and we found that the impact of impaired renal function on prognosis after STEMI did not significantly differ between genders. Sederholm Lawesson et al. [12] reported that the association between impaired renal function and outcome after STEMI is stronger in women than in men. In that study no prognostic impact of renal function on clinical outcomes was observed in men; in contrast, in women each 10 mL/min/1.73 m 2 increment of eGFR was associated with 63% lower risk of death. The interaction test between gender and impaired renal function showed significant differences with respect to mortality. However, we found the opposite in our analysis. The 1-year mortality after STEMI proportionally increased as eGFR decreased, and this impact persisted even after adjusting for potential confounders in both genders. The hazard ratios in each eGFR category were similar in both genders, and the interaction test showed insignificant results. Sederholm Lawesson et al. [12] included an insufficient number of patients (total, 247) to demonstrate a gender effect between impaired renal function and mortality. Chen et al. [3] also reported that gender might influence the prognostic effect of impaired renal function in coronary artery disease patients. In that study they analyzed 1,609 patients enrolled from 1996 to 1997. However, given the recent remarkable advances in treatment of STEMI patients and in quality control, the significance of that study is limited. Recently, Damman et al. [11] have raised questions about previous studies that investigated gender effects on impaired renal function and clinical outcomes. They showed a stronger association between impaired renal function and outcomes in both genders. In contrast to previous studies, they found that hazard ratios at each eGFR category were higher in men than in women, and an interaction test between gender and impaired renal function showed significance in overall mortality. Although, Damman et al. [11] analyzed a relatively large number of patients compared to previous studies, the data were based on a single-center-registry, and a significantly higher hazard ratio in men was needed for verification.
Our study has several distinctive advantages compared to previous studies. Firstly, the study population was derived from a multi-center online registry and large-scale cohort populations were analyzed. This is likely to improve statistical reliability. Secondly, the CKD-EPI equation was used to estimate eGFR. This equation was recently described as an improved method of GFR estimation that is more accurate and provides stronger prognostic value than older methods [14, 15] .
The present study has several limitations. Although we adjusted for multiple confounding factors, it is possible that some unmeasured confounders remain. Moreover, the assessment of kidney function was based on a single serum creatinine value obtained at the time of presentation to the hospital. This value could have been affected by hemodynamic or metabolic status.
Conclusions
In conclusion, we demonstrated that impaired renal function was an independent prognostic factor after STEMI in both genders, and confirmed that the impact of impaired renal function on prognosis after STEMI did not significantly differ between genders. Our study does not support the notion that gender influences the association between impaired renal function and clinical outcome after STEMI. Our findings broaden current understanding of the role of gender in patients with STEMI.
